metoclopramide has been researched along with Carcinoma, Epidermoid in 20 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoclopramide (MCP) was given i." | 6.65 | Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984) |
| " The nausea and vomiting were reasonably well controlled with methylprednisolone and metoclopramide." | 3.67 | [Clinical study of chemotherapy (PPM therapy) with cisplatin, peplomycin and mitomycin C in squamous cell lung cancer]. ( Arai, S; Honda, Y; Ito, T; Kato, M; Kawata, Y; Kori, Y; Koyama, M, 1986) |
| "Metoclopramide (MCP) was given i." | 2.65 | Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984) |
| "Biopsy revealed a pulmonary squamous cell carcinoma, which was inoperable." | 1.62 | Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced? ( Dias, RF; Diniz, MML; Nobre, VA; Santos, BC, 2021) |
| "Intradermally injected human squamous cell carcinoma cells were grown to 40 to 80 mm3 in athymic nude mice and irradiated with 675-nm light (75 J/cm2, 75 mW/cm2) 24 hours after the intraperitoneal injection of SiPc IV (1." | 1.29 | Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck. ( Antunez, AR; Jafri, A; Megerian, CA; Stepnick, DW; Werning, JW; Zaidi, SI, 1995) |
| "Nude mice with xenografted squamous cell carcinoma where injected with cisplatin 5 mg/kg i." | 1.29 | Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue. ( Johnsson, A; Kjellén, E; Pero, R; Wennerberg, J, 1996) |
| "Metoclopramide was not found to affect the LD50/30 in this in vivo model." | 1.28 | Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation. ( Kjellén, E; Lybak, S; Nilsson, P; Pero, RW; Tomaszewicz, A; Wennerberg, J, 1992) |
| "Two human squamous cell carcinoma lines of the head and neck xenografted to nude mice have been used." | 1.28 | Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck. ( Kjellén, E; Lybak, S; Pero, R; Wennerberg, J, 1990) |
| "Metoclopramide was administered intravenously during the study and was able to predict a good response to oral therapy." | 1.28 | Tumor-associated gastroparesis with esophageal carcinoma. Use of intravenous metoclopramide during radionuclide gastric emptying studies to predict clinical response. ( Choe, AI; Fleischer, DE; Ziessman, HA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 12 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, RF | 1 |
| Diniz, MML | 1 |
| Santos, BC | 1 |
| Nobre, VA | 1 |
| Cognetti, F | 1 |
| Pinnarò, P | 1 |
| Carlini, P | 1 |
| Conti, EM | 1 |
| Cortese, M | 1 |
| Pollera, CF | 1 |
| McGonagle, ME | 1 |
| Vrabec, DP | 1 |
| Werning, JW | 1 |
| Stepnick, DW | 1 |
| Jafri, A | 1 |
| Megerian, CA | 1 |
| Antunez, AR | 1 |
| Zaidi, SI | 1 |
| Sugasawa, M | 1 |
| Nibu, K | 1 |
| Ichimura, K | 1 |
| Kaga, K | 1 |
| Asai, M | 1 |
| Senba, T | 1 |
| Yamasoba, T | 1 |
| Tsunoda, K | 1 |
| Abe, K | 1 |
| Kobayashi, T | 1 |
| Cullen, MH | 1 |
| Pero, RW | 4 |
| Olsson, A | 2 |
| Sheng, Y | 1 |
| Hua, J | 1 |
| Möller, C | 1 |
| Kjellén, E | 7 |
| Killander, D | 2 |
| Marmor, M | 1 |
| Huang, H | 2 |
| Brun, E | 1 |
| Ewers, SB | 1 |
| Jarlman, O | 1 |
| Knöös, T | 1 |
| Malmström, P | 1 |
| Tennvall, J | 1 |
| Johnsson, A | 1 |
| Wennerberg, J | 5 |
| Pero, R | 3 |
| Lybak, S | 3 |
| Nilsson, P | 1 |
| Tomaszewicz, A | 1 |
| El-Sayed, S | 1 |
| Symonds, RP | 1 |
| Robertson, AG | 1 |
| Paul, J | 1 |
| McGarva, J | 1 |
| Kori, Y | 1 |
| Koyama, M | 1 |
| Kato, M | 1 |
| Honda, Y | 1 |
| Kawata, Y | 1 |
| Arai, S | 1 |
| Ito, T | 1 |
| Choe, AI | 1 |
| Ziessman, HA | 1 |
| Fleischer, DE | 1 |
| Rosenblatt, E | 1 |
| Lev, LM | 1 |
| Robinson, E | 1 |
| Thies, PW | 1 |
| Zafar, M | 1 |
1 review available for metoclopramide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Progress in identifying clinical relevance of inhibition, stimulation and measurements of poly ADP-ribosylation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Clinica | 1995 |
5 trials available for metoclopramide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cl | 1984 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
A phase I/II evaluation of metoclopramide as a radiosensitiser in patients with inoperable squamous cell carcinoma of the lung.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Metoclopram | 1995 |
Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 1990 |
High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; | 1988 |
14 other studies available for metoclopramide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced?
Topics: Aged; Antiemetics; Carcinoma, Squamous Cell; Constipation; Gastrointestinal Agents; Gastrointestinal | 2021 |
Hypomotility of the stomach following gastric pull up.
Topics: Bethanechol Compounds; Carcinoma, Squamous Cell; Drug Therapy, Combination; Esophageal Neoplasms; Fe | 1984 |
Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, D | 1995 |
[Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 1994 |
Combined acupuncture and medicinal anesthesia for neolarynx reconstruction.
Topics: Acupuncture Analgesia; Adjuvants, Anesthesia; Adult; Aged; Anesthetics, Local; Carcinoma, Squamous C | 1995 |
[Application of acupuncture anesthesia combining with drugs during neolarynx reconstruction].
Topics: Acupuncture Analgesia; Adjuvants, Anesthesia; Adult; Aged; Carcinoma, Squamous Cell; Ear, External; | 1995 |
Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cisplatin; DNA Adducts; Drug Synergism; Female; Ki | 1996 |
Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation.
Topics: Animals; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Male; Metoclopramid | 1992 |
Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck.
Topics: Animals; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Drug Therapy, Combination | 1991 |
Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck.
Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Head and Neck Neop | 1990 |
[Clinical study of chemotherapy (PPM therapy) with cisplatin, peplomycin and mitomycin C in squamous cell lung cancer].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcin | 1986 |
Tumor-associated gastroparesis with esophageal carcinoma. Use of intravenous metoclopramide during radionuclide gastric emptying studies to predict clinical response.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Gastric Emptying; Humans; Injections, Intraven | 1989 |
Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female | 1989 |
Metoclopramide-induced fever.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fever; Humans; Met | 1986 |